Lv5
1272 积分 2021-01-04 加入
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1个月前
已完结
PIK3CA mutations in vascular malformations
5个月前
已完结
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
5个月前
已完结
Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options
5个月前
已完结
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Non-Squamous EGFR-Wildtype NSCLC in the Phase 2 LUMINOSITY Trial
9个月前
已完结
Litifilimab (BIIB059), a promising investigational drug for cutaneous lupus erythematosus
11个月前
已完结
Hepatocellular Carcinoma
1年前
已完结
MET alterations in advanced non-small cell lung cancer
1年前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
1年前
已完结
Tepotinib Treatment in Patients With MET Exon 14–Skipping Non–Small Cell Lung Cancer
1年前
已完结
皖公网安备34019202002308
